Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC44402 Nidulin

    巢曲菌素

    A depsidone
  3. GC44388 NF-κB Control

    SN50M

    A negative control peptide used with NF-κB inhibitor
  4. GC44363 Neoaureothin

    NSC 260179, Spectinabilin

    A bacterial metabolite
  5. GC44361 Nemadipine A An L-type calcium channel blocker
  6. GC44263 Myrtillin

    氯化飞燕草素葡萄糖苷; Delphinidin 3-O-glucoside chloride; Delphinidin 3-O-β-glucoside chloride

    桃金娘苷(Delphinidin 3-o-glucoside)是一种花青素单体,主要分布于各种植物中,可用高效液相色谱法(HPLC)质谱法(Mass)和核磁共振法进行定性和定量分析(NMR)。

  7. GC44260 Myristoyl Coenzyme A (hydrate)

    Myristoyl-CoA, Tetradecanoyl Coenzyme A, Tetradecanoyl-CoA

    A substrate for N-myristoyltransferase

  8. GC44251 MTIC

    替莫唑胺代谢物- MTIC

    A DNA alkylating agent
  9. GC44243 Monohydroxy Melphalan (hydrochloride)

    Hydroxymelphalan

    A DNA alkylating agent
  10. GC44227 MM-206 A STAT3 inhibitor
  11. GC44135 Mca-VDQMDGW-K(Dnp)-NH2 (ammonium salt)

    Caspase-3 Fluorogenic Substrate V

    A caspase-3 fluorogenic substrate
  12. GC44097 LY303511 (hydrochloride) An inhibitor of cell proliferation
  13. GC44096 LY293111

    Etalocib; VML 295

    A LTB4 receptor antagonist
  14. GC44087 L-threo-PPMP (hydrochloride)

    L-threo-1-phenyl-2-Palmitoylamino-3-morpholino-1-propanol

    An inhibitor of glucosylceramide synthetase
  15. GC44085 L-Sulforaphene

    莱菔素

    A natural isothiocyanate
  16. GC44080 LLP-3 Induces apoptosis by blocking Survivin/Ran interactions
  17. GC44006 Kinsenoside

    金线莲苷

    A glycoside with diverse biological activities
  18. GC44002 Kibdelone C

    (+)-Kibdelone C

    A heterocyclic polyketide
  19. GC43995 Kazusamycin B

    CL 1957E, Hydroxyleptomycin A, PD 124895

    A bacterial metabolite
  20. GC43922 Isovaleryl-L-carnitine (chloride)

    L-异戊酰基肉碱

    An acylcarnitine
  21. GC43894 IKK2 Inhibitor VI

    5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide

    An inhibitor of IKK2
  22. GC43816 Heptelidic Acid

    萜烯七脂酸; Koningic acid

    A selective, irreversible GAPDH inhibitor
  23. GC43776 Glycochenodeoxycholic Acid (sodium salt)

    甘氨鹅脱氧胆酸钠; Chenodeoxycholylglycine sodium salt; Sodium glycochenodeoxycholate

    A primary bile acid
  24. GC43762 GLP-1 (7-36) amide (trifluoroacetate salt)

    Glucagon-like Peptide 1 (7-36) amide

    A GLP-1R agonist
  25. GC43742 Gemcitabine-13C,15N2 (hydrochloride) An internal standard for the quantification of gemcitabine
  26. GC43732 Ganglioside GM3 Mixture (sodium salt)

    单唾液神经节苷酯GM3; Hematoside; Sialosyllactosylceramide

    A mixture of ganglioside GM3
  27. GC43729 Ganglioside GD3 Mixture (sodium salt)

    双唾液酸神经节苷脂GD3; Disialosyllactosylceramide

    A mixture of ganglioside GD3
  28. GC43723 Galactosylsphingosine (d18:1)

    神经鞘氨醇半乳糖苷,Galactosylsphingosine

    A bioactive sphingolipid
  29. GC43689 Fluphenazine-N-2-chloroethane (hydrochloride)

    Fluphenazine-N-mustard, FNM, FPCE, SKF-7171A

    A nitrogen mustard derivative of fluphenazine
  30. GC43668 FITC-C6-YVADAP-K(Dnp) (trifluoroacetate salt)

    FITC-C6-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH

    A caspase-1 fluorogenic substrate
  31. GC43643 Eupenifeldin A cytotoxic fungal metabolite
  32. GC43625 Erucin

    芥酸精; 甘油三芥酸酯

    An isothiocyanate with neuroprotective and antioxidant effects
  33. GC43610 Enniatin A1

    恩镰孢菌素 A1

    An ionophore antibiotic
  34. GC43606 Endothelin-1 (human, porcine) (trifluoroacetate salt)

    ET-1

    A peptide vasoconstrictor
  35. GC43565 Doxorubicinol (hydrochloride)

    13-Dihydroadriamycin hydrochloride

    A doxorubicin metabolite
  36. GC43515 D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)

    Ins(1,3,4,5,6)P5, 1,3,4,5,6IP5

    An anticancer inositol phosphate
  37. GC43514 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt)

    Ins(1,3,4,5,6)P5, 1,3,4,5,6IP5 (sodium salt)

    An anticancer inositol phosphate
  38. GC43463 DiIC1(5)

    1,1',3,3,3',3'-六甲基吲哚双碳菁碘

    A signal-off fluorescent probe
  39. GC43462 Dihydrolipoic Acid

    (+/-)-二氢硫辛酸,DHLA

    A reduced form of α-lipoic acid
  40. GC43452 Diffractaic Acid

    地弗地衣酸

    A lichen metabolite with diverse biological activities
  41. GC43439 Diallyl Trisulfide

    二烯丙基三硫化物

    A natural H2S donor
  42. GC43436 Diacetylcercosporin A perylenequinone that has diverse biological activities
  43. GC43408 Deoxycholic Acid (sodium salt hydrate)

    一水脱氧胆酸钠,Cholanoic Acid sodium hydrate; Desoxycholic acid sodium hydrate

    A secondary bile acid
  44. GC43406 Delphinidin (chloride)

    氯化花翠素

    Natural vasorelaxant and inhibitor of EGFRs and HATs
  45. GC43379 Darinaparsin

    Dimethylarsinic glutathione

    A dimethylated arsenic linked to glutathione with anticancer activities
  46. GC43368 D,L-1′-Acetoxychavicol Acetate

    D,L-1\'-乙酰氧基胡椒酚乙酸酯

    A natural exportin 1 inhibitor
  47. GC43361 Cytostatin (sodium salt) A selective PP2A inhibitor
  48. GC43357 CytoCalcein™ Violet 500 A fluorogenic dye
  49. GC43356 CytoCalcein™ Violet 450 A fluorogenic dye
  50. GC43346 Cyclopamine-KAAD

    3-酮-N-氨基乙基-N'-氨基己酰二氢肉桂酰环杷明,Cyclopamine-KAAD

    A potent inhibitor of hedgehog signaling
  51. GC43326 CRT0066101 (hydrochloride) Protein kinase D (PKD) is a serine/threonine protein kinase that is activated by diacylglycerol, commonly downstream of PKC signaling.

Items 1251 to 1300 of 2517 total

per page

Set Descending Direction